RLAY - CIK 0001812364
The table below shows Relay Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $204.59M | $91.56M | $113.94M | $93.54M | $152.36M | $134.13M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $658.46M |
| $624.01M |
| $680.39M |
| $739.66M |
| $865.13M |
| $704.27M |
| Property, plant & equipment | $1.22M | $2.36M | $3.46M | $5.15M | $7.21M | $8.35M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $699.61M | $670.00M | $728.84M | $799.36M | $930.12M | $772.55M |
| Accounts payable | $4.10M | $2.75M | $5.18M | $8.45M | $6.87M | $11.17M |
| Total current liabilities | $29.75M | $32.60M | $32.52M | $37.05M | $46.97M | $45.04M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $57.43M | $62.29M | $63.18M | $78.28M | $91.25M | $90.81M |
| Retained earnings | -$2.09B | -$1.96B | -$1.89B | -$1.82B | -$1.66B | -$1.57B |
| Total equity | $642.18M | $607.71M | $665.66M | $721.08M | $838.86M | $681.74M |